<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1805210731
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Atropine Sulfate Aguettant
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ATROPINE SULFATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intramuscular and intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection in pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        306.60
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="LABORATOIRE AGUETTANT" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            LABORATOIRE AGUETTANT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 416]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Arabian Health Care Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AGUETTANT LABORATORIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A03BA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pharmacotherapeutic group: Belladonna alkaloids, tertiary amines.<br />ATC code: A03BA01.</p><p>Atropine belongs to a group of medicines known as anticholinergics. An anticholinergic is a substance that blocks the neurotransmitter acetylcholine in the central and peripheral nervous system. &nbsp;It is used in emergency situations when the heart beats too slowly, as an antidote to for example organophosphate insecticide or nerve gas poisoning and in mushroom poisoning.<br />It can be used as part of the premedication before a general anaesthesia. It can also be used to prevent side effects of other drugs which are used to reverse the effects of muscle relaxants used after surgery.&nbsp;<br />ATROPINE SULFATE 0.1 mg/mL solution for injection in pre-filled syringe is used to treat adults and children from birth with a body weight superior to 3 kg.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use ATROPINE SULFATE if you:<br />&bull;&nbsp;&nbsp; &nbsp;are allergic (hypersensitive) to atropine or any of the other ingredients of this medicine (listed in section 6)<br />&bull;&nbsp;&nbsp; &nbsp;have urinary difficulties,<br />&bull;&nbsp;&nbsp; &nbsp;have elevated pressure in your eye (glaucoma),<br />&bull;&nbsp;&nbsp; &nbsp;have oesophagus disease (achalasia of oesophagus), a blockage in your intestine (paralytic ileus), or acute form of colonic distension (toxic megacolon).</p><p>Warnings and precautions<br />Talk to your doctor before using ATROPINE SULFATE if you have:<br />&bull;&nbsp;&nbsp; &nbsp;hyperthyroidism,&nbsp;<br />&bull;&nbsp;&nbsp; &nbsp;prostatic disease,<br />&bull;&nbsp;&nbsp; &nbsp;heart failure,&nbsp;<br />&bull;&nbsp;&nbsp; &nbsp;liver or kidney disease,<br />&bull;&nbsp;&nbsp; &nbsp;some cardiac diseases,&nbsp;<br />&bull;&nbsp;&nbsp; &nbsp;stomach disease, such as pyloric narrowing,<br />&bull;&nbsp;&nbsp; &nbsp;chronic bronchitis,&nbsp;<br />&bull;&nbsp;&nbsp; &nbsp;fever,<br />&bull;&nbsp;&nbsp; &nbsp;if you are a child or elderly,<br />&bull;&nbsp;&nbsp; &nbsp;myasthenia gravis (severe muscle weakness),<br />&bull;&nbsp;&nbsp; &nbsp;heartburn (reflux).</p><p>Other medicines and ATROPINE SULFATE&nbsp;<br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines:&nbsp;<br />&bull;&nbsp;&nbsp; &nbsp;tricyclic antidepressants,&nbsp;<br />&bull;&nbsp;&nbsp; &nbsp;some antihistamines,&nbsp;<br />&bull;&nbsp;&nbsp; &nbsp;medicines for Parkinson&#39;s disease,&nbsp;<br />&bull;&nbsp;&nbsp; &nbsp;phenothiazine, clozapine or neuroleptic drugs (for mental illness),&nbsp;<br />&bull;&nbsp;&nbsp; &nbsp;quinidine or disopyramide (for heart disease),&nbsp;<br />&bull;&nbsp;&nbsp; &nbsp;antispasmodic medications (for irritable bowel syndrome).&nbsp;</p><p>Pregnancy and breastfeeding</p><p>Pregnancy<br />Limited data from the use of atropine in pregnant women indicate no adverse effects on pregnancy or on the health of the fetus. Atropine crosses the placenta. Intravenous administration of atropine during pregnancy or at term may cause a faster heart rate in the fetus and the mother. This medicine should only be administered during pregnancy after careful consideration of the benefits and risks of the treatment.</p><p>Breast-feeding<br />Small amounts of atropine may pass into breast milk and may have effects on the infant. Atropine may inhibit the production of breast milk. Your doctor will consider the benefit of breast-feeding against the benefit of the treatment. Breast-feeding should be discontinued if the decision to use the treatment is maintained. However, if it is decided during treatment to continue breast-feeding, your doctor will perform extra examinations on the infant.&nbsp;</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.<br />&nbsp;<br />Driving and using machines<br />Atropine injection may cause confusion or blurred vision. You should not drive or operate machinery after receiving an injection.</p><p>ATROPINE SULFATE contains sodium<br />This medicinal product contains less than 1 mmol of sodium (23 mg) per syringe, that is to say essentially &quot;sodium-free.&quot;</p><p>These contraindications do not apply in case of life-threatening emergencies.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Your doctor will decide the correct dosage for you and how and when the injection will be given.</p><p>The usual dosages are:</p><p>As premedication before anaesthesia&nbsp;<br />Intravenous (IV) administration immediately before surgery; if necessary an intramuscular administration 30-60 minutes before surgery is possible.<br />Adults: 0.3-0.6 mg IV &nbsp;<br />Children: 0.01-0.02 mg/kg, dose adjusted according to patient&rsquo;s response and tolerance (maximum 0.6 mg per dose).</p><p>To reverse effects of muscle relaxants:&nbsp;<br />Adults: 0.6-1.2 mg IV with neostigmine.<br />Children: 0.02 mg/kg IV</p><p>In low heartbeat, heart block or cardiac arrest:<br />Adults:<br />-&nbsp;&nbsp; &nbsp;Sinus bradycardia (low heartbeat): 0.5 mg IV, every 2-5 minutes until the desired heart rate is achieved.<br />-&nbsp;&nbsp; &nbsp;AV block (Block the transmission of the contraction between the atrium and the ventricle): 0.5 mg IV, every 3-5 minutes (maximum 3 mg).<br />Children: 0.02 mg/kg IV in a single dose (maximum dose 0.6 mg).</p><p>As an antidote to organophosphorus poisoning (insecticides, or nerve gas), to anticholinesterases and in muscarinic mushroom poisoning:&nbsp;<br />Adults: 0.5-2 mg IV, can be repeated after 5 minutes and subsequently every 10-15 minutes as required<br />Children: 0.02 mg/kg possibly repeated several times until signs and symptoms disappear.</p><p>Other forms of this medicine may be more suitable where a dose above 0.5 mg is required.&nbsp;</p><p>Use in children<br />Atropine is used to treat children from birth with a body weight superior to 3 kg.<br />If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p><p>This injection will be given to you by a doctor or nurse, it is unlikely that you will be given too much atropine. If you think you have been given too much Atropine, you feel your heart beating very fast, you are breathing quickly, have a high temperature, feel restless, confused, have hallucinations or lose co-ordination, you must tell the person giving you the injection.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />The side effects depend on the dose you are given and usually disappear when the treatment is discontinued.</p><p>Rarely an allergic reaction may develop. This may cause skin rashes, severe itching, peeling of the skin, swelling of the face (especially around the lips and eyes), tightening of the throat and difficulty breathing or swallowing, fever, dehydration, shock and fainting. These are all very serious side effects. Tell your doctor immediately if you experience any of these side effects. You may need urgent medical attention.</p><p>Very common side effects (may affect more than 1 in 10 people)<br />&bull;&nbsp;&nbsp; &nbsp;visual disturbances (widening of the pupils, difficulty focussing, blurred vision, inability to tolerate light),<br />&bull;&nbsp;&nbsp; &nbsp;reduced bronchial secretion,<br />&bull;&nbsp;&nbsp; &nbsp;dry mouth (difficulty in swallowing and talking, feeling thirsty),<br />&bull;&nbsp;&nbsp; &nbsp;constipation and heartburn (reflux),<br />&bull;&nbsp;&nbsp; &nbsp;reduced secretion of gastric acid,<br />&bull;&nbsp;&nbsp; &nbsp;loss of taste,<br />&bull;&nbsp;&nbsp; &nbsp;nausea,<br />&bull;&nbsp;&nbsp; &nbsp;vomiting,<br />&bull;&nbsp;&nbsp; &nbsp;bloated feeling,<br />&bull;&nbsp;&nbsp; &nbsp;lack of sweating,<br />&bull;&nbsp;&nbsp; &nbsp;skin dryness,<br />&bull;&nbsp;&nbsp; &nbsp;hives,<br />&bull;&nbsp;&nbsp; &nbsp;rash.</p><p>Common side effects (may affect up to 1 in 10 people)<br />&bull;&nbsp;&nbsp; &nbsp;excitement (especially with higher dosages),<br />&bull;&nbsp;&nbsp; &nbsp;loss of coordination (especially with higher dosages),<br />&bull;&nbsp;&nbsp; &nbsp;confusion (especially with higher dosages),<br />&bull;&nbsp;&nbsp; &nbsp;hallucinations (especially with higher dosages),<br />&bull;&nbsp;&nbsp; &nbsp;overheated body,<br />&bull;&nbsp;&nbsp; &nbsp;certain heart conditions (rapid heart beat, irregular heart beat, temporary further slowing down of heart beat),<br />&bull;&nbsp;&nbsp; &nbsp;flushing,<br />&bull;&nbsp;&nbsp; &nbsp;difficulty in passing urine.</p><p>Uncommon side effects (may affect up to 1 in 100 people)<br />&bull;&nbsp;&nbsp; &nbsp;psychotic reactions.</p><p>Rare side effects (may affect up to 1 in 1,000 people)<br />&bull;&nbsp;&nbsp; &nbsp;allergic reactions,<br />&bull;&nbsp;&nbsp; &nbsp;fits (seizures),<br />&bull;&nbsp;&nbsp; &nbsp;drowsiness.</p><p>Very rare side effects (may affect up to 1 in 10,000 people)<br />&bull;&nbsp;&nbsp; &nbsp;severe hypersensitivity reaction,<br />&bull;&nbsp;&nbsp; &nbsp;irregular heart beat, including ventricular fibrillation,<br />&bull;&nbsp;&nbsp; &nbsp;chest pain,<br />&bull;&nbsp;&nbsp; &nbsp;spike in blood pressure.</p><p>Not known (frequency cannot be estimated from the available data)<br />&bull;&nbsp;&nbsp; &nbsp;headache,<br />&bull;&nbsp;&nbsp; &nbsp;restlessness,<br />&bull;&nbsp;&nbsp; &nbsp;unsteady walking and balance problems,<br />&bull;&nbsp;&nbsp; &nbsp;sleeplessness.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is stated on the carton, the syringe and blister after EXP. The expiry date refers to the last day of that month.<br />This medicine must be stored at or below 30&deg;C.<br />Do not use this medicine if you notice visible signs of deterioration.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp; &nbsp;The active substance is atropine sulfate:&nbsp;<br />Each ml of solution for injection contains 0.1 mg atropine sulfate monohydrate, equivalent to 0.083 mg atropine.<br />Each 5 ml syringe contains 0.5 mg atropine sulfate monohydrate, equivalent to 0.415 mg atropine.</p><p>-&nbsp;&nbsp; &nbsp;The other ingredients are:<br />Sodium chloride, concentrated hydrochloric acid (for pH adjustment), water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This medicinal product is a clear and colourless solution for injection in a sterile 5 ml polypropylene pre-filled syringe.
Boxes of 10 syringes.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>LABORATOIRE AGUETTANT<br />1, RUE ALEXANDER FLEMING<br />69007 LYON<br />France</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                April 2019
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">المجموعة الدوائية العلاجية: قلويدات البلادونا، الأمينات الثلاثية<br />الرمز في النظام التشريحي&nbsp; الدوائي العلاجي &quot;ATC&quot; :A03BA01<br />ينتمي الأتروبين إلى مجموعة من الأدوية المعروفة باسم مضادات الكولين. مضادات الكولين هي مواد تمنع عمل الناقل العصبي أستيل كولين في الجهاز العصبي المركزي والمحيطي. يتم استخدامه في حالات الطوارئ عندما يتباطأ نبض القلب بشدة، وكترياق، على سبيل المثال، عند التعرّض للمبيدات الحشرية من مجموعة الفوسفات العضوي أو مع التسمم بغاز الأعصاب أو مع التسمم بالفطر.</p><p dir="RTL">ويمكن استخدامه كأحد الأدوية التي تُعطى قبل التخدير العام. كما يمكن استخدامه لمنع حدوث الأعراض الجانبية للعقاقير الأخرى التي تستخدم لعكس آثار ارتخاء العضلات بعد الجراحة.</p><p dir="RTL">كبريتات الأتروبين 0,1 مجم/مل محلول للحقن في مِحقنة مُسبقة التعبئة مُعد للاستخدام لدى البالغين والأطفال بما فيهم الرضع ممن تتجاوز أوزانهم 3 كجم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم كبريتات الأتروبين إذا</strong><br />- كان لديك حساسية (شديدة الحساسية) نحو الأتروبين أو أي من المكونات الأخرى لهذا الدواء (المذكورة<br />&nbsp;&nbsp; في الفقرة رقم 6)،</p><p dir="RTL">- كنت تعاني من صعوبات في التبول،</p><p dir="RTL">- كان لديك ارتفاع الضغط في عينيك (الجلوكوما)،</p><p dir="RTL">- كنت مصاب بمرض في المريء (تعذّر الارتخاء المريئي)، أو انسداد في الأمعاء (عِلَّوص شللي)، أو<br />&nbsp; &nbsp;شكل حاد من انتفاخ القولون (تضخم القولون السام).</p><p dir="RTL"><br />لا تنطبق موانع الاستخدام هذه في حالات الطوارئ التي تهدد الحياة.<br />&nbsp;</p><p dir="RTL"><strong>المحاذير والإحتياطات</strong></p><p dir="RTL">تحدث إلى طبيبك قبل استخدام كبريتات الأتروبين إذا كان لديك:</p><p dir="RTL">- فرط نشاط الغدة الدرقية،</p><p dir="RTL">- مرض البروستاتا،</p><p dir="RTL">- فشل القلب،</p><p dir="RTL">- أمراض الكبد أو الكلى،</p><p dir="RTL">- بعض أمراض القلب،</p><p dir="RTL">- أمراض المعدة، مثل تضيق البواب &quot;الفتحة بين المعدة والإثني عشر&quot;،</p><p dir="RTL">- التهاب الشعب الهوائية المزمن،</p><p dir="RTL">- حمى،</p><p dir="RTL">- إذا كنت من الأطفال أو كبار السن،</p><p dir="RTL">- الوهن العضلي الوبيل (ضعف العضلات الشديد)،</p><p dir="RTL">- حرقة (ارتجاع مريئي).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأدوية الأخرى وكبريتات الأتروبين&nbsp; </strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول، أو قد تناولت مؤخرا أو قد تتناول أي أدوية أخرى:</p><p dir="RTL">- مضادات الاكتئاب ثلاثية الحلقات،</p><p dir="RTL">- بعض مضادات الهستامين،</p><p dir="RTL">- الأدوية التي تعالج مرض باركنسون،</p><p dir="RTL">- فينوثيازين، كلوزابين أو مضادات الذهان (للأمراض العقلية)،</p><p dir="RTL">- الكينيدين أو الديسوبيراميد (لأمراض القلب)،</p><p dir="RTL">- الأدوية المضادة لتشنج الأمعاء (لمتلازمة القولون العصبي).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong><br /><em>الحمل</em></p><p dir="RTL">تشير البيانات المحدودة من استخدام الأتروبين في النساء الحوامل إلى عدم وجود آثار ضارة على الحمل أو على صحة الجنين. الأتروبين يعبر خلال المشيمة. قد يؤدي إعطاء الأتروبين عن طريق الوريد أثناء الحمل أو عند نهاية الحمل إلى ارتفاع معدل ضربات القلب لدى كل من الجنين والأم. يجب إعطاء هذا الدواء أثناء الحمل بعد دراسة متأنية لفوائد ومخاطر العلاج فقط.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>الرضاعة الطبيعية</em></p><p dir="RTL">قد تنتقل كميات صغيرة من الأتروبين إلى حليب الثدي وقد يكون لها تأثيرات على الرضيع. كما قد يمنع الأتروبين إنتاج حليب الأم. سوف يأخذ طبيبك في عين الاعتبار الموازنة بين فائدة الرضاعة الطبيعية لطفلك مقابل فائدة العلاج لك. يجب التوقف عن الرضاعة الطبيعية إذا قرر لك الطبيب الاستمرار في استخدام العلاج. ومع ذلك، إذا تقرر أثناء العلاج مواصلة الرضاعة الطبيعية، فسيقوم طبيبك بإجراء فحوصات إضافية للرضيع.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنتِ حاملاً أو مرضعة، تعتقدين أنك قد تكونين حاملاً أو تخططين لإنجاب طفل، استشيري طبيبك أو الصيدلي قبل تناول هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">قد يسبب حقْن الأتروبين الارتباك أو عدم وضوح الرؤية. يجب تجنّب القيادة أو تشغيل الآلات بعد تلقي الحقن.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>كبريتات الأتروبين تحتوي على الصوديوم.</strong></p><p dir="RTL">يحتوي هذا المنتج الطبي على أقل من 1 مليمول من الصوديوم (23 مجم) في كل محقنة، أي أنّه &quot;خالٍ من الصوديوم&quot; بشكل أساسي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سيقرر طبيبك الجرعة المناسبة لك وكيف ومتى سيتم إعطاء الحقن.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الجرعات المعتادة هي:<br /><em><u>كأحد الأدوية المستخدمة قبل التخدير</u></em><br />يُعطى بالحقن الوريدي قبل الجراحة مباشرة؛ كما يمكن إعطاؤه بالحقن العضلي قبل الجراحة بمدة تتراوح بين 30-60 دقيقة إذا لزم الأمر.</p><p dir="RTL">البالغون: 0,3-0,6 مجم تُحقن في الوريد<br />الأطفال: 0,01-0,02 مجم/كجم، يتم ضبط الجرعة تبعًا لاستجابة المريض وتحمّله (الحد الأقصى 0,6 مجم لكل جرعة)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em><u>لعكس آثار مرخيات العضلات</u></em></p><p dir="RTL">البالغون: 0,6-1,2 مجم عن طريق الوريد (IV) مع نيوستيغمين.<br />الأطفال: 0,02 مجم/كجم بالحقن الوريدي (IV)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em><u>لعلاج تباطؤ نبضات القلب، إحصار القلب أو السكتة القلبية</u></em></p><p dir="RTL">الكبار:</p><p dir="RTL">&bull; بطء القلب الجيبي (انخفاض نبضات القلب): 0,5 مجم عن طريق الوريد، كل 2-5 دقائق حتى يتم<br />&nbsp; الوصول إلى معدل ضربات القلب المطلوب.</p><p dir="RTL">&bull; إحصار القلب الجيبي البُطيني (منع انتقال الانقباض بين الأذين والبطين): 0,5 مجم عن طريق الوريد،<br />&nbsp;&nbsp;كل 3-5 دقائق (جرعة إجمالية 3 مجم كحد أقصى).<br />الأطفال: 0,02 مجم/كجم كجرعة واحدة (الجرعة القصوى 0,6 مجم)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em><u>كترياق عند التسمم بالفسفور العضوي (المبيدات الحشرية، أو غاز الأعصاب)، ومضادات الكُولينِستيراز والتسمم بالفطر المسكاريني:</u></em></p><p dir="RTL">للبالغين: 0,5-2 مجم اعتمادا على حالة المريض واستجابته، يمكن تكرارها بعد 5 دقائق وبعد ذلك كل 10-15 دقيقة حسب الحاجة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تكون الأشكال الأخرى من هذا الدواء أكثر ملاءمة عندما تكون الجرعة المطلوبة أكبر من 0,5 مجم.</p><p dir="RTL"><br /><u>استخدامه لدى الأطفال</u><br />يُستخدم الأتروبين في علاج الأطفال بما فيهم الرضع ممن تتجاوز أوزانهم 3 كجم.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، اسأل طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">سيتم إعطاء هذا الحقن لك من قبل طبيب أو ممرض، ولذلك من غير المرجح أن يتم حقنك بجرعة أكثر مما ينبغي. إذا كنت تعتقد أنك تلقيت الكثير من الأتروبين، كأن تشعر بأن قلبك ينبض بسرعة شديدة، وأنك تتنفس بسرعة، أو تشعر بارتفاع درجة حرارتك، أو بالتململ أو التشوش، أو لديك هلوسة، أو فقدت القدرة على التناسق العضلي أثناء الحركة، يجب أن تخبر الشخص المسؤول عن حقنك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع جميع الأدوية، يمكن أن يسبب هذا الدواء أعراضًا جانبية، وإن كانت لا تحدث لدى جميع من يستخدمه.</p><p dir="RTL">تعتمد الأعراض الجانبية على الجرعة التي تُعطى لك وعادة ما تختفي عند توقف العلاج.</p><p dir="RTL">&nbsp;</p><p dir="RTL">نادرا ما قد يحدث رد فعل تحسسي. قد يتسبب ذلك في حدوث طفح جلدي وحكة شديدة وتقشير الجلد وتورم في الوجه (خاصة حول الشفاه والعينين) وانتفاخ الحلق وصعوبة في التنفس أو البلع والحمى والجفاف والصدمة والإغماء. هذه كلها أعراض جانبية خطيرة للغاية. أخبر طبيبك على الفور إذا كنت تعاني من أي من هذه الأعراض الجانبية. قد تحتاج إلى عناية طبية عاجلة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>أعراض جانبية شائعة جدًا (قد تؤثر على أكثر من شخص من كل 10 أشخاص)</u></p><p dir="RTL">&bull; الاضطرابات البصرية (اتساع حدقة العين، صعوبة التركيز، عدم وضوح الرؤية، عدم القدرة على تحمل الضوء)،</p><p dir="RTL">&bull; انخفاض إفراز الشعب الهوائية،</p><p dir="RTL">&bull; جفاف الفم (صعوبة البلع والتحدث والشعور بالعطش)،</p><p dir="RTL">&bull; الإمساك وحرقة (ارتجاع مَعدي مريئي)،</p><p dir="RTL">&bull; انخفاض إفراز حمض المعدة،</p><p dir="RTL">&bull; فقدان حاسة التذوق،</p><p dir="RTL">&bull; الغثيان،</p><p dir="RTL">&bull; القيء،</p><p dir="RTL">&bull; الشعور بالانتفاخ،</p><p dir="RTL">&bull; عدم التعرق،</p><p dir="RTL">&bull; جفاف الجلد،</p><p dir="RTL">&bull; شرى،</p><p dir="RTL">&bull; الطفح الجلدي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>الأعراض الجانبية الشائعة (قد تؤثر على ما يصل إلى 1 من كل 10 أشخاص)</u></p><p dir="RTL">&bull; الإثارة (وخاصة مع جرعات أعلى)،</p><p dir="RTL">&bull; فقدان التناسق العضلي أثناء الحركة (وخاصة مع جرعات أعلى)،</p><p dir="RTL">&bull; الارتباك (وخاصة مع جرعات أعلى)،</p><p dir="RTL">&bull; هلوسة (خاصة مع جرعات أعلى)،</p><p dir="RTL">&bull; ارتفاع درجة حرارة الجسم،</p><p dir="RTL">&bull; أعراض معينة في القلب (سرعة ضربات القلب، عدم انتظام ضربات القلب، زيادة في التباطؤ المؤقت<br />&nbsp; لنبضات القلب)،</p><p dir="RTL">&bull; احمرار الوجه،</p><p dir="RTL">&bull; صعوبة في التبول.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>الأعراض الجانبية الغير شائعة (قد تؤثر على ما يصل إلى 1 من كل 100 شخص)</u></p><p dir="RTL">&bull; ردود الفعل الذهانية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>الأعراض الجانبية النادرة (قد تؤثر على ما يصل إلى 1 من كل 1000 شخص)</u></p><p dir="RTL">&bull; الحساسية،</p><p dir="RTL">&bull; النوبات (التشنّجات)،</p><p dir="RTL">&bull; النعاس.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>الأعراض الجانبية النادرة جدا (قد تؤثر على ما يصل إلى 1 من كل 10000 شخص)</u></p><p dir="RTL">&bull; رد فعل تحسسي شديد،</p><p dir="RTL">&bull; اضطراب ضربات القلب، بما في ذلك الرجفان البطيني،</p><p dir="RTL">&bull; ألم في الصدر،</p><p dir="RTL">&bull; ارتفاع في ضغط الدم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>ذات التردد الغير معروف (لا يمكن تقدير التردد من البيانات المتاحة)</u></p><p dir="RTL">&bull; صداع الراس،</p><p dir="RTL">&bull; الأرق،</p><p dir="RTL">&bull; المشي غير المستقر ومشاكل في التوازن،</p><p dir="RTL">&bull; عدم القدرة على النوم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفظ &nbsp;هذا الدواء بعيدا عن مرأى ومتناول الأطفال.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العلبة والمحقنة والغلاف. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">يجب أن يتم حفظ هذا الدواء في درجة حرارة &nbsp;30 درجة مئوية أو أقل.</p><p dir="RTL">لا تستخدم هذا الدواء إذا لاحظت علامات تغيّر واضحة.</p><p dir="RTL">لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. هذه التدابير سوف تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">- المادة الفعّالة هي كبريتات الأتروبين:</p><p dir="RTL">&nbsp;&nbsp; يحتوي كل 1 مل من محلول الحقن على 0,1 مجم كبريتات الأتروبين أحادي الهيدرات؛ أي ما يعادل<br />&nbsp;&nbsp; 0,083 مجم من الأتروبين.<br />&nbsp;&nbsp; تحتوي كل مِحقنة سعتها 5 مل على 0,5 مجم كبريتات الأتروبين أحادي الهيدرات، أي ما يعادل 0,415<br />&nbsp;&nbsp; مجم أتروبين.</p><p dir="RTL">- المكونات الأخرى هي: كلوريد الصوديوم، حمض الهيدروكلوريك المركز (لتعديل الرقم الهيدروجيني)، الماء<br />&nbsp;&nbsp; المُخصّص للحقن.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">هذا المنتج الطبي هو محلول صافي وعديم اللون مُعد للحقن ويتوفر في مِحقنة مُعقمة مُسبقة التعبئة سعتها 5 مل مصنوعة من مادة البولي بروبيلين.</p><p dir="RTL">يسوّق المنتج في علب تحتوي كل منها على 10 محاقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>معامل أغيتان</strong><br />1، طريق أليكسندر فلِمنغ<br />69007 ليون<br />فرنسا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
             تمت آخر مراجعة لهذه النشرة بتاريخ أكتوبر 2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ATROPINE SULFATE 0.1 mg/mL, solution for injection in pre-filled syringe.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each ml of solution for injection contains 0.1 mg atropine sulfate monohydrate, equivalent to 0.083 mg atropine.
Each 5 ml syringe contains 0.5 mg atropine sulfate monohydrate, equivalent to 0.415 mg atropine.

Excipient with known effect: sodium
Each ml of solution for injection contains 3.5 mg equivalent to 0.154 mmol of sodium.
Each 5 ml syringe contains 17.7 mg equivalent to 0.770 mmol of sodium.

For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection in pre-filled syringe.
Clear and colourless solution.
pH 3.2 – 4.0.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATROPINE SULFATE 0.1 mg/mL, solution for injection in pre-filled syringe is indicated in adults and in paediatric population from birth, but with a body weight superior to 3 kg (see section 4.2).<br />-&nbsp;&nbsp; &nbsp;As a pre-anaesthetic medication to prevent vagal reactions associated with tracheal intubation and surgical manipulation,&nbsp;<br />-&nbsp;&nbsp; &nbsp;To limit the muscarinic effects of neostigmine, when given postsurgically to counteract non-depolarising muscle relaxants<br />-&nbsp;&nbsp; &nbsp;Treatment of hemodynamically compromising bradycardia and/ or atrioventricular block due to excessive vagal tone in emergency situation<br />-&nbsp;&nbsp; &nbsp;Cardiopulmonary resuscitation: to treat symptomatic bradycardia and AV block<br />-&nbsp;&nbsp; &nbsp; As antidote following overdosage or poisoning with acetylcholinesterase-inhibitors e.g. anticholinesterases, organophosphorus, carbamates and muscarinic mushrooms</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATROPINE SULFATE 0.1 mg/mL, solution for injection in pre-filled syringe must be administered under medical supervision.</p><p>Posology:</p><p>Pre-anaesthetic medication&nbsp;<br />Intravenous administration immediately before surgery; if necessary an intramuscular administration 30-60 minutes before surgery is possible.</p><p>Adults:<br />0.3 &ndash; 0.6 mg IV (3 &ndash; 6 ml)</p><p>Paediatric population:<br />The usual dose in children is between 0.01-0.02 mg/kg body weight (maximum 0.6 mg per dose), dosage should be adjusted according to the patient&rsquo;s response and tolerance.</p><p>In combination with neostigmine to limit its muscarinic effects:</p><p>Adults:&nbsp;<br />0.6-1.2 mg IV (6 to 12 ml)</p><p>Paediatric population<br />0.02 mg/kg IV</p><p>Treatment of hemodynamically compromising bradycardia, atrioventricular block, cardiopulmonary resuscitation:</p><p>Adults:<br />-&nbsp;&nbsp; &nbsp;Sinus bradycardia: 0.5 mg IV (5ml), every 2-5 minutes until the desired heart rate is achieved.<br />-&nbsp;&nbsp; &nbsp;AV block: 0.5 mg IV (5ml), every 3-5 minutes (maximum 3 mg)</p><p>Paediatric population&nbsp;</p><p>0.02 mg/kg IV in a single dose (maximum dose 0.6 mg).</p><p><br />As an antidote to organophosphates (pesticides, nerve gases), to cholinesterase inhibitors and in muscarinic mushroom poisoning:</p><p>Intravenous use.</p><p>Adults:<br />0.5 - 2 mg atropine sulfate (5 - 20 ml), can be repeated after 5 minutes and subsequently every 10-15 minutes as required, until signs and symptoms disappear (this dose may be exceeded many times).</p><p>Paediatric population:&nbsp;<br />0.02 mg atropine sulfate/kg body weight possibly repeated several times until signs and symptoms disappear.</p><p>Dose adjustments</p><p>In general, dosage should be adjusted according to patient&rsquo;s response and tolerance.<br />Dosage to a total maximum dose of 3 mg in adults and 0.6 mg in children is usually increased until adverse effects become intolerable; then a slight reduction in dosage generally yields the maximum dosage tolerated by the patient.</p><p>Paediatric Population<br />This medicinal product is not appropriate to deliver a dose of less than 0.5 ml and should therefore not be used in neonates for which the body weight is inferior to 3 kg (see section 4.1).<br />The dosage ranges for the paediatric weight groups as stated below are values for guidance. The usual dose in children is between 0.01-0.02 mg/kg body weight (maximum 0.6 mg per dose), dosage should be adjusted according to the patient&rsquo;s response and tolerance.</p><p>Body weight&nbsp;<br />(kg)&nbsp;&nbsp; &nbsp;Dose of 0.01 mg/kg body weight&nbsp;</p><p>Atropine 0.1 mg/mL Solution for Injection (ml)&nbsp;&nbsp; &nbsp;Dose of 0.02 mg/kg body weight</p><p>Atropine 0.1 mg/mL Solution for Injection (ml)<br />3 - 5&nbsp;&nbsp; &nbsp;0.5 ml&nbsp;&nbsp; &nbsp;0.5-1.0 ml<br />5-10&nbsp;&nbsp; &nbsp;0.5-1.0 ml&nbsp;&nbsp; &nbsp;1.0-2.0 ml<br />10 - 15&nbsp;&nbsp; &nbsp;1.0-1.5 ml&nbsp;&nbsp; &nbsp;2.0-3.0 ml<br />15 - 20&nbsp;&nbsp; &nbsp;1.5-2.0 ml&nbsp;&nbsp; &nbsp;3.0-4.0 ml<br />20 - 30&nbsp;&nbsp; &nbsp;2.0-3.0 ml&nbsp;&nbsp; &nbsp;4.0-6.0 ml<br />30 - 50&nbsp;&nbsp; &nbsp;3.0-5.0 ml&nbsp;&nbsp; &nbsp;6.0 ml</p><p>Special populations<br />Caution is advised for patients with renal or hepatic impairment and in elderly (see section 4.4).</p><p>Method of administration<br />Atropine is administered by intravenous injection or intramuscular injection. Other pharmaceutical forms/strengths may be more appropriate in the cases where a dose above 0.5 mg is required.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
-	Hypersensitivity to the active substance or to any of the excipients
-	Closed-angle glaucoma
-	Risk of urinary retention because of prostatic or urethral disease 
-	Achalasia of the esophagus, paralytic ileus, and toxic megacolon

All these contra-indications are however not relevant in life-threatening emergencies (such as bradyarrhythmia, poisoning).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Use with caution in case of:<br />-&nbsp;&nbsp; &nbsp;Prostatic enlargement<br />-&nbsp;&nbsp; &nbsp;Renal or hepatic insufficiency<br />-&nbsp;&nbsp; &nbsp;Cardiac insufficiency, arrhythmias, hyperthyroidism<br />-&nbsp;&nbsp; &nbsp;Chronic obstructive pulmonary disease, as a reduction in bronchial secretions may lead to the formation of bronchial plugs<br />-&nbsp;&nbsp; &nbsp;Intestinal atonia in elderly<br />-&nbsp;&nbsp; &nbsp;Pyloric stenosis<br />-&nbsp;&nbsp; &nbsp;Fever, or when ambient temperature is high<br />-&nbsp;&nbsp; &nbsp;In children and elderly, who may be more susceptible to its adverse effects<br />-&nbsp;&nbsp; &nbsp;In reflux oesophagitis, as atropine may delay gastric emptying, decrease gastric motility and relax oesophageal sphincter</p><p>Atropine should not be given to patients with myasthenia gravis unless given in conjunction with anticholinesterase.</p><p>Atropine administration should not delay implementation of external pacing for unstable patients, particularly those with high-degree (Mobitz type II second-degree or third-degree) block.</p><p>Antimuscarinics block vagal inhibition of the SA nodal pacemaker and should thus be used with caution in patients with tachyarrhythmias, congestive heart failure or coronary heart disease.</p><p>This medicinal product contains sodium. Sodium level is lower than 1 mmol per syringe, i.e. &lsquo;without sodium&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Combinations to be taken into account<br />Other drugs with anticholinergic activity, such as tricyclic antidepressants, some H1-antihistamines, antiparkinsonian drugs, disopyramide, mequitazine, phenothiazines, neuroleptic drugs, atropinic antispasmodics, clozapine and quinidine, because of the risk of potentialisation of atropinic adverse effects (urinary retention, constipation, dry mouth).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Data on a limited number of exposed pregnancies indicate no adverse effects of atropine on pregnancy or on the health of the fetus/new-born child.<br />Animal studies did not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3).<br />Studies of the pharmacokinetics of atropine in mother and fetus in late pregnancy indicated that atropine rapidly crosses the placental barrier. Intravenous administration of atropine during pregnancy or at term may cause tachycardia in the fetus and the mother.&nbsp;<br />Atropine should not be used during pregnancy unless clearly necessary.</p><p>Breast-feeding<br />Small amounts of atropine may pass into human breast milk. Infants have an increased sensitivity to the anticholinergic effects of atropine. Atropine may inhibit the production of milk, particularly upon repeated use. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from treatment taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman. If it is decided during treatment to continue breastfeeding, the child should be monitored for anticholinergic effects.</p><p>Fertility<br />There are no data on effects of this atropine sulfate on fertility in humans. Atropine sulfate reduced fertility in male rats, presumably as a consequence of an inhibitory effect on the transport of sperm and semen during the process of emission.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Atropine may cause confusion or blurred vision and patients should be advised of it.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pattern of adverse effects seen with atropine can mostly be related to their pharmacological actions at muscarinic and, at high doses, nicotinic receptors. Adverse effects are dose-related and usually reversible when therapy is discontinued. The most common effects occurring with relatively small doses are visual disturbances, reduced bronchial secretion, dry mouth, constipation, reflux, flushing, difficulty in micturition and dryness of the skin. Transient bradycardia may develop followed by tachycardia, with palpitations and arrhythmias.&nbsp;</p><p>The evaluation of adverse reactions is based on the following definition of frequency:&nbsp;<br />Very Common: &ge;1/10;&nbsp;<br />Common: &ge;1/100 to &lt;1/10;&nbsp;<br />Uncommon: &ge;1/1,000 to &lt;1/100;&nbsp;<br />Rare: &ge;1/10,000 to &lt;1/1,000;&nbsp;<br />Very rare: &lt;1/10,000;&nbsp;<br />Not known: cannot be estimated from the available data&nbsp;<br />&nbsp; &nbsp; &nbsp; &nbsp;Frequency</p><p>System&nbsp;<br />Organ Class&nbsp;&nbsp; &nbsp;Very Common<br />(&ge;1/10)&nbsp;&nbsp; &nbsp;Common<br />(&ge;1/100 to &lt;1/10)&nbsp;&nbsp; &nbsp;Uncommon<br />(&ge;1/1,000 to &lt;1/100)&nbsp;&nbsp; &nbsp;Rare<br />(&ge;1/10,000 to &lt;1/1,000)&nbsp;&nbsp; &nbsp;Very Rare<br />(&lt;1/10,000)&nbsp;&nbsp; &nbsp;Not known<br />(cannot be estimated from the available data)<br />Immune system disorders&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;Allergic reactions&nbsp;&nbsp; &nbsp;Anaphylaxis&nbsp;&nbsp; &nbsp;<br />Nervous system disorders&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;Excitement, incoordination, mental confusion, and/or hallucinations (especially with higher dosages), hyperthermia&nbsp;&nbsp; &nbsp;Psychotic reactions&nbsp;&nbsp; &nbsp;Seizure, drowsiness &nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;Headache, restlessness, ataxia, insomnia<br />Eye disorders&nbsp;&nbsp; &nbsp;Visual disturbances (mydriasis, inhibition of accommodation, blurred vision, photophobia)&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;<br />Cardiac disorders&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;Tachycardia (arrhythmias, transient exacerbation of bradycardia)&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;Atrial arrhythmias, ventricular fibrillation, angina, hypertensive crisis&nbsp;&nbsp; &nbsp;<br />Vascular disorders&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;Flushing&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;<br />Respiratory, thoracic and mediastinal disorders&nbsp;&nbsp; &nbsp;Reduced bronchial secretion&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;<br />Gastrointestinal disorders&nbsp;&nbsp; &nbsp;Dryness of the mouth (difficulty in swallowing and talking, thirst), parasympathetic inhibition of gastrointestinal tract (constipation and reflux), inhibition of gastric secretion, loss of taste, nausea, vomiting, bloated feeling&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;<br />Skin and subcutaneous tissue disorders&nbsp;&nbsp; &nbsp;Anhidrosis, urticaria, rash&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;<br />Renal and urinary disorders&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;Inhibition of the parasympathetic control of the urinary bladder, urinary retention&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp;</p><p>Paediatric population<br />Infants, children and children with spastic paralysis or brain damage may be more susceptible to antimuscarinic effects.</p><p>Special populations<br />Atropine may cause excitement, incoordination, confusion and/or hallucinations especially in the elderly. An epidemiological study similarly reported lower cognitive performance in elderly patients receiving antimuscarinics.<br />Patients with Down syndrome may be more susceptible to antimuscarinic effects.</p><p>To reports any side effect(s):</p><p>Saudi Arabia:&nbsp;</p><p>&bull;&nbsp;&nbsp; &nbsp;The National Pharmacovigilance Centre (NPC):</p><p>-&nbsp;&nbsp; &nbsp;Fax: +966-11-205-7662<br />-&nbsp;&nbsp; &nbsp;Call NPC at +966-11-2038222, Ext 2317-2356-2340<br />-&nbsp;&nbsp; &nbsp;SFDA Call Center: 19999<br />-&nbsp;&nbsp; &nbsp;E-mail: npc.drug@sfda.gov.sa<br />-&nbsp;&nbsp; &nbsp;Website: https://ade.sfda.gov.sa/</p><p><br />Other GCC States:</p><p>-&nbsp;&nbsp; &nbsp;Please contact the relevant competent authority.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms:&nbsp;<br />Flushing and dryness of the skin, dilated pupils with photophobia, dry mouth and tongue accompanied by a burning sensation, difficulty in swallowing, tachycardia, rapid respiration, hyperpyrexia, nausea, vomiting, hypertension, rash and excitement.&nbsp;<br />Symptoms of CNS stimulation include restlessness, confusion, hallucinations, paranoid and psychotic reactions, incoordination, delirium and occasionally convulsions.&nbsp;<br />In severe overdose, drowsiness, stupor and CNS depression may occur with coma, circulatory and respiratory failure and death.</p><p>Treatment:<br />Treatment should be supportive. An adequate airway should be maintained. Diazepam may be administered to control excitement and convulsions but the risk of CNS depression should be considered.&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Belladonna alkaloids, tertiary amines.<br />ATC code: A03BA01.</p><p>Atropine is an antimuscarinic agent which competitively antagonises acetylcholine at postganglionic nerve endings, thus affecting receptors in the exocrine glands, smooth muscle, cardiac muscle and the central nervous system.</p><p>Peripheral effects include decreased production of saliva, sweat, nasal, lachrymal and gastric secretions, decreased intestinal motility and inhibition of micturition.</p><p>Atropine increases sinus rate and sinoatrial and AV conduction. Usually heart rate is increased, but there may be an initial bradycardia.</p><p>Atropine inhibits secretions throughout the respiratory tract and relaxes bronchial smooth muscle producing bronchodilation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Following intravenous administration, the peak increase in heart rate occurs within 2 to 4 minutes. Peak plasma concentrations of atropine after intramuscular administration are reached within 30 minutes, although peak effects on the heart, sweating and salivation may occur 1 hour after intramuscular administration.</p><p>Distribution<br />Plasma levels after intramuscular and intravenous injection are comparable at 1 hour. Atropine is distributed widely throughout the body and crosses the blood brain barrier and the placenta barrier.&nbsp;</p><p>Biotransformation<br />Atropine is incompletely metabolised in the liver and is excreted in the urine as unchanged drug and metabolites. About 50% of the dose is excreted within 4 hours and 90% in 24 hours.</p><p>Elimination<br />The elimination half-life is about 2 to 5 hours. Up to 50% of the dose is protein bound.</p><p>Paediatric Population<br />Children, particularly those younger than two years, may be more susceptible to the actions of atropine. The elimination half-life is more than doubled in children less than two years compared to adults.</p><p>Elderly<br />The elimination half-life of atropine is more than doubled in the elderly (&gt;65 years old) compared to adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Effects in non-clinical studies were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use.&nbsp;<br />Atropine sulfate reduced fertility in male rats, presumably as a consequence of an inhibitory effect on the transport of sperm and semen during the process of emission.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;Sodium chloride<br />Concentrated hydrochloric acid (for pH adjustment)<br />Water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5 ml solution in a pre-filled syringe (polypropylene) without needle, individually packaged in a transparent blister, available in box of 10.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Instructions for use:<br />Be careful to strictly respect the protocol for the use of the syringe.<br />The pre-filled syringe is for single patient only. Discard syringe after use. DO NOT REUSE.<br />The content of un-opened and un-damaged blister is sterile and must not be opened until used.&nbsp;</p><p>The product should be inspected visually for particles and discoloration prior to administration. Only clear colourless solution free from particles or precipitates should be used.&nbsp;</p><p>The product should not be used if the tamper evident seal on syringe (plastic cover to the end cap) is broken.</p><p>The external surface of syringe is sterile until blister is opened.<br />&emsp;<br />1)&nbsp;&nbsp; &nbsp;Withdraw the pre-filled syringe from the sterile blister.</p><p>2)&nbsp;&nbsp; &nbsp;Push on the plunger to free the bung.</p><p>3)&nbsp;&nbsp; &nbsp;Twist off the end cap to break the seal.</p><p><br />4)&nbsp;&nbsp; &nbsp;Check the syringe seal (plastic cover to the end cap and seal under end cap) has been completely removed. If not, replace the cap and twist again.</p><p><br />5)&nbsp;&nbsp; &nbsp;Expel the air by gently pushing the plunger.&nbsp;</p><p><br />6)&nbsp;&nbsp; &nbsp;Connect syringe to vascular access device or to needle.<br />Push the plunger to inject the required volume.</p><p>The needle gauge appropriate for use with the syringe are 23 to 20 gauge for IV administration and 23 to 21 gauge for IM administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                LABORATOIRE AGUETTANT
1, rue Alexander Fleming
69007 Lyon
France
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                April 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>